News

For yet another year, HACRO – Hellenic Association of CROs proudly participated in the 18th Greece Race for the Cure®, held on Sunday, October 4, in Athens. HACRO members joined more than 58,000 participants in this major event, highlighting the importance of prevention, awareness, support, and solidarity in the fight against breast cancer. The Greece

Patient information and education are essential prerequisites for their meaningful participation in clinical research. As part of the three-day educational programme of the EUPATI Greece Patient Academy, organised by the Greek Patients Association, the President of HACRO – Hellenic Association of CROs, Evangelia (Lia) Koraki, participated as a speaker in the educational session “Critical Reading

The Memorandum of Understanding between HACRO and the MSc Programme “Clinical Trials: Design and Conduct” of Medical School of National and Kapodistrian University of Athens (NKUA), strengthens the connection between academic education and clinical research practice. Athens, July 3, 2026 – The Hellenic Association of CRO’s (HACRO) and the Master’s Programme “Clinical Trials: Design and

Strong messages on enhancing competitiveness and attracting investment to Greece through targeted initiatives and a unified direction across all stakeholders Athens, April 27, 2026 — The panel discussion on clinical research at the 11th Delphi Economic Forum concluded with great success, highlighting the prospects for strengthening Greece’s position on the European map. The session titled

HACRO participated in the scientific conference organized by the National Organization for Medicines (EOF) on Wednesday, February 4, 2026, titled “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps.” The President, Ms. Evangelia Koraki, in her presentation entitled “The pivotal role of EOF in the progress of clinical research in Greece” highlighted

The Greek Patients’ Association launches the first EUPATI Patient Academy in Greece (https://academy.greekpatient.gr/), a comprehensive educational program aimed at strengthening the role of patients in pharmaceutical research, clinical trials, and health policy development. Empowering patients through continuous education and access to reliable information can play a decisive role in shaping a modern, equitable, and efficient

Rare Diseases Greece presents three groundbreaking, interactive tools that offer valuable support to individuals living with rare diseases in Greece. These tools aim to improve access to therapies, advocate for patient rights, and enhance understanding of the rare disease landscape in the country. These tools promote transparency and empower citizens to actively participate in the

The new Clinical Trial Map, made available by the European Medicines Agency (EMA) through the public online platform CTIS, represents a particularly significant advancement in the field of clinical research in Europe. This innovative and effective tool enables patients and healthcare professionals to identify, in real-time, ongoing clinical trials across Europe by geographic region and